June 19, 2008
Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets
WALTHAM, Mass., June 19 /PRNewswire/ -- According to Millennium Research Group's Japanese Markets for Peripheral Vascular (PV) Devices 2008 report, the aortic stent graft market will increase at a compound annual growth rate (CAGR) of nearly 60% through 2012 due to market entry of both abdominal and thoracic stent grafts in 2006 and 2008, respectively. These new devices and a growing physician preference for minimally invasive procedures will also be key drivers. While growth will not be as high as in Japan, the more established Canadian stent graft market will also expand significantly, at a CAGR of close to 20% through 2012.
In both Canada and Japan, continued introduction of innovative stent graft technologies will allow more patients with aortic disease to be treated using endovascular techniques rather than surgery. For instance, in June 2008, W.L. Gore's TAG was the first thoracic stent graft to receive regulatory approval in Japan. The first abdominal stent grafts were approved in 2006. Procedures will experience robust growth over the next five years as new devices are introduced into the Japanese and Canadian markets, extending the treatable patient population. Successful aortic repair using stent grafts has encouraged Japanese and Canadian physicians to adopt the procedures, expanding procedures and revenues in both countries."Device innovation is improving the success rates of aortic stent grafts while also expanding the treatable patient population," says Ryan Brown, Analyst at Millennium Research Group. "As these devices become increasingly available in relatively underpenetrated markets, growing patient awareness of and demand for minimally invasive aortic procedures will drive the adoption of aortic stent grafts."
The Japanese and Canadian Markets for Peripheral Vascular Devices 2008 reports provide coverage of all key industry competitors, including Boston Scientific, Cook Medical, Cordis, Terumo, and W.L. Gore, among others. Global coverage of this report also includes US, Europe, Asia Pacific, and Latin America.
About Aortic Stent Grafts
The aorta, the main artery leaving the heart, splits into two iliac arteries that transport blood to the lower extremities. An aneurysm (the weakening and bulging of a blood vessel or artery) directly above the iliac bifurcation is referred to as an abdominal aortic aneurysm (AAA); one located in the ascending aorta, aortic arch, or the descending thoracic aorta is referred to as a thoracic aortic aneurysm (TAA). Stent grafts, tubes composed of fabric supported by a metal mesh, are designed to fasten tightly to the artery above and below the aneurysm. Once in place, blood passes through the stent graft rather than pushing on the bulge of the aneurysm.
About Millennium Research Group
Millennium Research Group (http://www.mrg.net/), a Decision Resources, Inc. company (http://www.decisionresources.com/), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
Millennium Research Group
CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776,ext. 01, [email protected]
Web site: http://www.mrg.net/http://www.decisionresources.com/